Table 1

Clinical findings and response to treatment with oral valacyclovir
Patient Age,Sex Eye Virus Posterior extent (zone) Time to initial response (weeks) Time to complete resolution (weeks) Initial BCVA Final BCVA Laser Steroids Complications
1 79, M R Undetermined 1 1 5 20/200 20/40 No – Zone 1 OFSI RPE change at macula
2 39, M L Presumed VZV 3 1 1 20/20 20/20 No – Zone 1 No Nil
3 82, M R VZV on PCR 1 1 4 20/120 CFs Yes Oral prednisolone RD at 45 days
4 54, F L VZV on PCR 2 2 6 CFs 20/60 Yes Oral prednisolone Nil
5 36, M R HSV-2 on PCR 2 1 3 20/30 20/80 Yes Oral prednisolone RD at 35 days
6 36, M L Undetermined 3 1 3 20/20 20/16 No No Nil
7 33, M L Presumed HSV-1 1 2 5 HMs LP No – Zone 1 Oral prednisolone RD at 49 days
8 30, F R Presumed VZV 3 1 2 20/20 20/20 Yes No Nil
L Presumed VZV 2 1 2 20/30 20/20 Yes No Nil
9 81, M L Undetermined 2 1 6 20/20 20/40 Yes Oral prednisolone Nil

VZV = Varicella zoster virus; HSV = Herpes simplex virus; PCR = polymerase chain reaction; BCVA = best corrected visual acuity; CFs = count fingers; HMs = hand movements; LP = perception of light; OFSI = Orbital floor corticosteroid injection; RD = retinal detachment.

Taylor et al.

Taylor et al. BMC Ophthalmology 2012 12:48   doi:10.1186/1471-2415-12-48

Open Data